Eiso Hiyama

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Kenichiro Uemura · 3 shared papers, 2016–2023 · strength 0.38
   • Paper Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.10.019↗
   • Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
   • Paper Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. DOI 10.1038/bjc.2016.175↗
2. Kenjiro Okada · 2 shared papers, 2021–2023 · strength 0.32
   • Paper Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.10.019↗
   • Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
3. Shin’ya Takahashi · 2 shared papers, 2021–2023 · strength 0.32
   • Paper Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.10.019↗
   • Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
4. Takumi Harada · 1 shared paper, 2023 · strength 0.19
   • Paper Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.10.019↗
5. Tatsuaki Sumiyoshi · 1 shared paper, 2023 · strength 0.19
   • Paper Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.10.019↗
6. Ryuta Shintakuya · 1 shared paper, 2023 · strength 0.19
   • Paper Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.10.019↗
7. Yoshiaki Murakami · 2 shared papers, 2016–2021 · strength 0.19
   • Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
   • Paper Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. DOI 10.1038/bjc.2016.175↗
8. Naru Kondo · 2 shared papers, 2016–2021 · strength 0.19
   • Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
   • Paper Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. DOI 10.1038/bjc.2016.175↗
9. Taijiro Sueda · 2 shared papers, 2016–2021 · strength 0.19
   • Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
   • Paper Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. DOI 10.1038/bjc.2016.175↗
10. Takuro Yamaguchi · 1 shared paper, 2021 · strength 0.13
    • Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
11. Naoto Hadano · 1 shared paper, 2016 · strength 0.06
    • Paper Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. DOI 10.1038/bjc.2016.175↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.